Spinello Antinori to Coronavirus Infections
This is a "connection" page, showing publications Spinello Antinori has written about Coronavirus Infections.
Connection Strength
0.131
-
SARS-COV-2 infection: Across the border into the family. Travel Med Infect Dis. 2020 Jul - Aug; 36:101784.
Score: 0.028
-
Bacterial and fungal infections among patients with SARS-CoV-2 pneumonia. Infez Med. 2020 Jun 01; 28(suppl 1):29-36.
Score: 0.028
-
Compassionate remdesivir treatment of severe Covid-19 pneumonia in intensive care unit (ICU) and Non-ICU patients: Clinical outcome and differences in post-treatment hospitalisation status. Pharmacol Res. 2020 08; 158:104899.
Score: 0.028
-
Self-reported Olfactory and Taste Disorders in Patients With Severe Acute Respiratory Coronavirus 2 Infection: A Cross-sectional Study. Clin Infect Dis. 2020 07 28; 71(15):889-890.
Score: 0.007
-
Pulmonary post-mortem findings in a series of COVID-19 cases from northern Italy: a two-centre descriptive study. Lancet Infect Dis. 2020 10; 20(10):1135-1140.
Score: 0.007
-
30-day mortality in patients hospitalized with COVID-19 during the first wave of the Italian epidemic: A prospective cohort study. Pharmacol Res. 2020 08; 158:104931.
Score: 0.007
-
Off-label use of tocilizumab for the treatment of SARS-CoV-2 pneumonia in Milan, Italy. Eur J Intern Med. 2020 06; 76:36-42.
Score: 0.007
-
Tocilizumab for cytokine storm syndrome in COVID-19 pneumonia: an increased risk for candidemia? Autoimmun Rev. 2020 07; 19(7):102564.
Score: 0.007
-
How to handle patients with autoimmune rheumatic and inflammatory bowel diseases in the COVID-19 era: An expert opinion. Autoimmun Rev. 2020 07; 19(7):102574.
Score: 0.007
-
COVID-19, cytokines and immunosuppression: what can we learn from severe acute respiratory syndrome? Clin Exp Rheumatol. 2020 Mar-Apr; 38(2):337-342.
Score: 0.007